Navigation Links
New approaches needed to gauge safety of nanotech-based pesticides

CORVALLIS, Ore. Nanotechnology is about to emerge in the world of pesticides and pest control, and a range of new approaches are needed to understand the implications for public health, ensure that this is done safely, maximize the potential benefits and prevent possible risks, researchers say in a new report.

In a study published today in the International Journal of Occupational and Environmental Health, scientists from Oregon State University and the European Union outline six regulatory and educational issues that should be considered whenever nanoparticles are going to be used in pesticides.

"If we do it right, it should be possible to design nanoparticles with safety as a primary consideration, so they can help create pesticides that work better or are actually safer," said Stacey Harper, an assistant professor of nanotoxicology at Oregon State University. Harper is a national leader in the safety and environmental impacts of this science that deals with particles so extraordinarily small they can have novel and useful characteristics.

"Unlike some other applications of nanotechnology, which are further along in development, applications for pesticides are in their infancy," Harper said. "There are risks and a lot of uncertainties, however, so we need to understand exactly what's going on, what a particular nanoparticle might do, and work to eliminate use of any that do pose dangers."

A program is already addressing that at OSU, as part of the Oregon Nanoscience and Microtechnologies Institute.

The positive aspect of nanotechnology use with pesticides, researchers say, is that it might allow better control and delivery of active ingredients, less environmental drift, formulations that will most effectively reach the desired pest, and perhaps better protection for agricultural workers.

"If you could use less pesticide and still accomplish the same goal, that's a concept worth pursuing," Harper said.

But researchers need to be equally realistic about the dangers, she said. OSU labs have tested more than 200 nanomaterials, and very few posed any toxic concerns but a few did. In one biomedical application, where nanoparticles were being studied as a better way to deliver a cancer drug, six out of 40 evoked a toxic response, most of which was linked to a specific surface chemistry that scientists now know to avoid.

"The emergence of nanotechnology in the pesticide industry has already begun, this isn't just theoretical," said David Stone, an assistant professor in the OSU Department of Environmental and Molecular Toxicology. "But pesticides are already one of the most rigorously tested and regulated class of compounds, so we should be able to modify the existing infrastructure."

One important concern, the researchers said, will be for manufacturers to disclose exactly what nanoparticles are involved in their products and what their characteristics are. Another issue is to ensure that compounds are tested in the same way humans would be exposed in the real world.

"You can't use oral ingestion of a pesticide by a laboratory rat and assume that will tell you what happens when a human inhales the same substance," Stone said. "Exposure of the respiratory tract to nanoparticles is one of our key concerns, and we have to test compounds that way."

Future regulations also need to acknowledge the additional level of uncertainty that will exist for nano-based pesticides with inadequate data, the scientists said in their report. Tests should be done using the commercial form of the pesticides, a health surveillance program should be initiated, and other public educational programs developed.

Special assessments may also need to be developed for nanoparticle exposure to sensitive populations, such as infants, the elderly, or fetal exposure. And new methodologies may be required to understand nanoparticle effects, which are different from most traditional chemical tests.

"These measures will require a coordinated effort between governmental, industry, academic and public entities to effectively deal with a revolutionary class of novel pesticides," the researchers concluded in their report.


Contact: Stacey Harper
Oregon State University

Related biology technology :

1. Anavex reports animal study results as lead Alzheimers compound approaches phase 1 clinical trials
2. NDIA's Biometrics Conference to Address Practical Approaches to the President's Challenge of 'Connecting the Dots' and Implementing $1B for New and Additional Security
3. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
4. Synthesis and Purification of Peptide Libraries -- Innovative Approaches
5. Clostridium difficile Infection: Strategic Approaches for Better Outcomes
6. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
7. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
8. Ohio Third Frontier Internship Program Gives Students Skills Needed To Succeed in High-Tech Job Market
9. Dramatic changes in agriculture needed as world warms and grows, researchers say
10. Cautious Approach Needed Before Any Decision on EU Out-of-Quota Sugar Exports Is Taken
11. ISMPP Supports Best Practices and Transparency in Medical Publications: Better Understanding of Terms Such as Ghostwriting Needed
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
Breaking Biology News(10 mins):